Marjo Nylund

Predictors of risk of secondary progression in multiple sclerosis (2025)

Therapeutic Advances in Neurological Disorders

Laaksonen, Sini; Sucksdorff, Marcus; Vuorimaa, Anna; Kuhle, Jens; Nylund, Marjo; Rajander, Johan; Wahlroos, Saara; Matilainen, Markus; Saraste, Maija; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain (2025)

Sjöros, Tanja; Saraste, Maija; Matilainen, Markus; Nylund, Marjo; Koivumäki, Mikko; Kuhle, Jens; Leppert, David; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)

Journal of Neurology, Neurosurgery and Psychiatry

Ahola, Venla; Saraste, Maija; Nylund, Marjo; Matilainen, Markus; Luoma, Amelie; Vuorimaa, Anna; Lehto, Jussi; Laaksonen, Sini; Brockmann, Eeva-Christine; Kuhle, Jens; Leppert, David; Soukka, Tero; Lamminmäki, Urpo; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis (2025)

BMJ neurology open

Radford-Smith, Daniel E.; Yates, Abi G.; Kacerova, Tereza; Nylund, Marjo; Sucksdorff, Marcus; Matilainen, Markus; Willemse, Eline; Oechtering, Johanna; Maceski, Aleksandra Maleska; Leppert, David; Kuhle, Jens; Probert, Fay; Anthony, Daniel C.; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state (2025)

Journal of Neuroinflammation

Hyvärinen, Tanja; Tilvis, Johanna; Giudice, Luca; Tujula, Iisa; Nylund, Marjo; Ohtonen, Sohvi; Scoyni, Flavia; Jäntti, Henna; Virtanen, Lassi; Pihlava, Sara; Kattelus, Roosa; Skottman, Heli; Narkilahti, Susanna; Airas, Laura; Malm, Tarja; Hagman, Sanna

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis (2025)

Journal of Neuroinflammation

Nylund, Marjo; Lehto, Jussi; Matilainen, Markus; Rajander, Johan; Wahlroos, Saara; Sucksdorff, Marcus; Kuhlmann, Tanja; Airas, Laura

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Synaptic Density in Multiple Sclerosis (2025)

Neurology, Neuroimmunology and Neuroinflammation

Luoma, Amelie; Matilainen, Markus; Tuisku, Jouni Mikael; Aarnio, Richard; Nikkilä, Taru; Laaksonen, Sini; Koivumäki, Mikko; Honkonen, Eveliina; Nylund, Marjo; Wahlroos, Saara; Solin, Olof; Chen, Ming-Kai; Toyonaga, Takuya; Lehto, Jussi; Snellman, Anniina; Rinne, Juha O.; Airas, Laura M.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis (2025)

Nature Medicine

Klotz, Luisa; Smolders, Joost; Lehto, Jussi; Matilainen, Markus; Lütje, Lukas; Buchholz, Luzia; Albrecht, Stefanie; Walter, Carolin; Varghese, Julian; Wiendl, Heinz; Nylund, Marjo; Thomas, Christian; Gardberg, Maria; van den Bosch, Aletta M. R.; Airas, Laura; Huitinga, Inge; Kuhlmann, Tanja

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

A Novel Comprehensive Epigenomic Liquid Biopsy Assay Reveals Disease Biology in Multiple Sclerosis Patients from 1 mL of Plasma (2024)

Multiple Sclerosis

Beagan, Jonathan; Nylund, Marjo; Painter, Corrie; Saraste, Maija; Chmielecki, Juliann; Tran, Vy; Tamakloe, Tyrone; Matilainen, Markus; Eaton, Matthew; Barrett, Carl; Airas, Laura

(Abstrakti)

TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)

The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Multiple Sclerosis

Rajalehto, Olli; Saraste, Maija; Matilainen, Markus; Nylund, Marjo; Honkonen, Eveliina; Lehto, Jussi; Airas, Laura

(Konferenssiposteri)

Marjo

Nylund

Ota yhteyttä

Linkit

Julkaisut

Järjestä:

Predictors of risk of secondary progression in multiple sclerosis (2025)

Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain (2025)

Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)

Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis (2025)

Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state (2025)

Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis (2025)

Synaptic Density in Multiple Sclerosis (2025)

Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis (2025)

A Novel Comprehensive Epigenomic Liquid Biopsy Assay Reveals Disease Biology in Multiple Sclerosis Patients from 1 mL of Plasma (2024)

TSPO-PET-measurable microglial activity remains unaltered in cladribine-treated RRMS patients (2024)